首页 | 本学科首页   官方微博 | 高级检索  
     

肺腺癌T1N0M0的预后因素分析
引用本文:谈万联. 肺腺癌T1N0M0的预后因素分析[J]. 临床肺科杂志, 2002, 7(4): 6-7
作者姓名:谈万联
作者单位:南京胸科医院,210029
摘    要:
目的:探讨肺腺癌T1N0M0患预后的病理因素与生存率的关系。方法:回顾1994年-1997年经手术治疗的肺腺癌T1N0M0 34例。观察病理学特征并随访。结果:34例病例术后平均随访时间为5.1年,5年生存率为67.7%。肿瘤直径2-3cm;中心性纤维化>30%;有淋巴管腔的侵犯;细胞核Ⅲ级与肿瘤坏死>50%,明显降低5年生存率。结论:研究有利于检测出转移风险较大的患,使其及时接受辅助性系统治疗。

关 键 词:肺腺癌 T1N0M0 预后 因素分析 治疗

Prognostic factors in T1N0M0 adenocarcinoma of the lung
Tan wan Lian. Prognostic factors in T1N0M0 adenocarcinoma of the lung[J]. Journal of Clinical Pulmonary Medicine, 2002, 7(4): 6-7
Authors:Tan wan Lian
Affiliation:Tan wan Lian.Department of Pathology,Nanjing Chest Hospital,NanJing 210029
Abstract:
Objective To identify pathologic prognostic factors related to survival for patients with T 1N 0M 0 adenoma of the lung.Methods 34 cases of T 1N 0M 0 adenocarcinoma of the lung surgically resected during the period in 1994-1997 were eligible in retrospective study. Pathological features of original slides from all cases were re-examined.Results The mean overall follow-up was 5.1 years, and the 5-year survival was 67.7%. Features significantly associated with decreased 5-year survival were tumor size of 2-3 cm, increased central fibrosis, nuclear grade 3, lymphatic vascular invasion, and more than 50% tumor necrosis.Conclusion These histological features may be used in the identification of patients with T 1N 0M 0 who have an increased risk of metastasis in receiving adjuvant systemic therapy.
Keywords:lung adenocarcinoma T 1N 0M 0
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号